These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9562140)

  • 1. Recombinant human growth hormone for AIDS-associated wasting.
    Windisch PA; Papatheofanis FJ; Matuszewski KA
    Ann Pharmacother; 1998 Apr; 32(4):437-45. PubMed ID: 9562140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.
    Mulligan K; Tai VW; Schambelan M
    J Clin Endocrinol Metab; 1998 May; 83(5):1542-7. PubMed ID: 9589652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of human immunodeficiency virus wasting syndrome.
    Badowski M; Pandit NS
    Pharmacotherapy; 2014 Aug; 34(8):868-81. PubMed ID: 24782295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV wasting syndrome: treatment update.
    Balog DL; Epstein ME; Amodio-Groton MI
    Ann Pharmacother; 1998 Apr; 32(4):446-58. PubMed ID: 9562141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection.
    Lee PD; Pivarnik JM; Bukar JG; Muurahainen N; Berry PS; Skolnik PR; Nerad JL; Kudsk KA; Jackson L; Ellis KJ; Gesundheit N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2968-75. PubMed ID: 8768860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life.
    Roubenoff R
    Am J Manag Care; 2000 Sep; 6(9):1003-16. PubMed ID: 11184062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wasting syndrome--affordable treatments.
    James JS
    AIDS Treat News; 1995 Jul; (no 226):6-7. PubMed ID: 11362615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of growth hormone and other anabolic agents in AIDS wasting.
    Mulligan K; Tai VW; Schambelan M
    JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S202-9. PubMed ID: 10571456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.
    Mulligan K; Grunfeld C; Hellerstein MK; Neese RA; Schambelan M
    J Clin Endocrinol Metab; 1993 Oct; 77(4):956-62. PubMed ID: 8408471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What you need to know about AIDS wasting.
    AIDS Alert; 1999 Apr; 14(4):suppl 1-2. PubMed ID: 11366222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug to treat wasting syndrome.
    Common Factor; 1995 Apr; (no 10):19. PubMed ID: 11362344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement, weight lifting help wasting.
    AIDS Alert; 1996 Jun; 11(6):suppl 1-2. PubMed ID: 11363546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
    J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related cachexia: potential mechanisms and treatment.
    Von Roenn JH; Roth EL; Craig R
    Oncology; 1992; 49 Suppl 2():50-4. PubMed ID: 1461629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment guidelines for HIV-associated wasting.
    Nemechek PM; Polsky B; Gottlieb MS
    Mayo Clin Proc; 2000 Apr; 75(4):386-94. PubMed ID: 10761494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human growth hormone available for AIDS wasting.
    Gilden D
    GMHC Treat Issues; 1995 Jan; 9(1):9-11. PubMed ID: 11367383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone in HIV/AIDS: current uses and future prospects.
    Laurence J
    Pediatr AIDS HIV Infect; 1995 Oct; 6(5):281-91. PubMed ID: 11361393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.